细胞质和核NFATc3协同促进血管光滑肌肉细胞功能障碍,并驱动大动脉动脉瘤和剖析

Xiu Liu1, Li Zhao1, Deshen Liu1

  • 1Department of Cardiovascular Surgery, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.

PubMed
概括

血管光滑肌细胞 (VSMCs) 中激活T细胞c3 (NFATc3) 的核因子通过降解细胞外基质驱动大动脉动脉瘤和剖析 (AAD). 抑制NFATc3可能为AAD提供一种新的治疗策略.